| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,942 |
15,933 |
$1.14M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,898 |
3,281 |
$189K |
| 99215 |
Prolong outpt/office vis |
1,788 |
1,710 |
$130K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,162 |
3,211 |
$46K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
526 |
484 |
$19K |
| 80305 |
|
2,332 |
2,248 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
6,483 |
5,980 |
$16K |
| 99441 |
|
310 |
285 |
$11K |
| 90674 |
|
398 |
396 |
$8K |
| 82962 |
|
4,984 |
4,426 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
305 |
304 |
$6K |
| 86328 |
|
85 |
81 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
468 |
453 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,743 |
1,198 |
$2K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
223 |
212 |
$711.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
29 |
26 |
$672.13 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
379 |
342 |
$551.46 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
308 |
299 |
$280.43 |
| 90688 |
|
13 |
13 |
$252.46 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
75 |
73 |
$182.49 |
| 82044 |
|
65 |
63 |
$145.33 |
| 81002 |
|
57 |
52 |
$109.05 |
| 82570 |
|
37 |
37 |
$103.36 |
| 90662 |
|
136 |
131 |
$56.13 |
| 82948 |
|
14 |
13 |
$45.07 |
| G0008 |
Administration of influenza virus vaccine |
245 |
238 |
$5.83 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
279 |
246 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
229 |
195 |
$0.00 |
| G8404 |
Lower extremity neurological exam performed and documented |
77 |
69 |
$0.00 |
| 3077F |
|
283 |
258 |
$0.00 |
| 3078F |
|
603 |
544 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
33 |
31 |
$0.00 |
| 1160F |
|
13 |
13 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
185 |
154 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
16 |
16 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
42 |
41 |
$0.00 |
| G8484 |
Influenza immunization was not administered, reason not given |
30 |
27 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
15 |
12 |
$0.00 |
| 3072F |
|
39 |
30 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
58 |
54 |
$0.00 |
| 3074F |
|
688 |
611 |
$0.00 |
| 3080F |
|
126 |
115 |
$0.00 |
| 3008F |
|
764 |
676 |
$0.00 |
| 3079F |
|
395 |
368 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
314 |
274 |
$0.00 |
| 3044F |
|
146 |
133 |
$0.00 |
| G8405 |
Lower extremity neurological exam not performed |
26 |
26 |
$0.00 |
| 3075F |
|
145 |
141 |
$0.00 |
| 1125F |
|
20 |
20 |
$0.00 |